Cancer Gene Therapy Focus of Alliance for Cancer Gene Therapy 5th Anniversary Dinner
Posted on: Thursday, 28 September 2006, 09:02 CDT
GREENWICH, Conn., Sept. 28 /PRNewswire/ --
WHO: Gene therapy used to treat cancer has been a hot topic recently. The Alliance for Cancer Gene Therapy (ACGT), a unique non-profit organization dedicated to funding medical research in the area of gene therapy, has provided more than $14 million in research grants and is hosting its fifth anniversary dinner on Thursday, September 28, in Greenwich, Conn. Top cancer researchers from throughout the U.S. will be in attendance at this important event as well as representatives from major healthcare corporations such as Johnson & Johnson, EMD Lexigen, Merck KGaA, Genetech, ImClone and Introgen. Dr. Judah Folkman, Director of Vascular Biology in the Department of Surgery at Children's Hospital and Professor of Cell Biology at Harvard Medical School, is being recognized for his discovery and visionary leadership in the field of angiogenesis, the process of which new blood vessels grow. Dr. John I. Gallin, Director of the National Institutes of Health (NIH) Clinical Center in Bethesda, Md., and Associate Director for Clinical Research at the NIH, will introduce Dr. Folkman. WHAT: 6:30 - 7:20 pm -- private reception with scientific advisory committee (note: this is a good time for reporters to speak directly to the scientists) 7:20 pm -- Event chairman and ACGT Executive Director Margaret Cianci 7:30 pm -- Adjourn to the ballroom 7:45 pm -- President of ACGT Edward Netter opens event, followed by Chairman of Executive Committee Savio L.C. Woo, Ph.D., Professor and Chair of Gene and Cell Medicine, Mt. Sinai School of Medicine, New York 8:00 pm -- Edward Netter, Chairman and Founder of ACGT, and Jeffrey C. Keil, Chairman of the Executive Committee 8:15 pm -- Dr. John Galin, Director of the National Institutes of Health 8:25 pm -- Dr. Judah Folkman 8:45 pm -- Award presentation to Dr. Folkman 9:00 pm -- Dinner 9:45 pm -- ACGT Fellows acknowledged by Executive Director Margaret Cianci and Dr. Savio Woo, Chairman of the Scientific Advisory Committee WHEN: Thursday, September 28, 2006 **NOTE TO MEDIA: IF YOU ARE INTERESTED IN ATTENDING THE DINNER, PLEASE CONTACT JENIFER HOWARD FOR A PRESS PASS WHERE: Hyatt Hotel 1800 East Putnam Avenue, Old Greenwich, CT 06870 CONTACT: Jenifer Howard jhoward1@optonline.net 203-273-4246
Alliance for Cancer Gene Therapy (ACGT)
CONTACT: Jenifer Howard, +1-203-273-4246, jhoward1@optonline.net
Source: PRNewswire
Related Articles
- Loma Linda University to Dedicate Proton Treatment Center to Cancer Therapy Pioneer James M. Slater, M.D.
- ARIAD Grants Second Commercial License to Its Patented ARGENT(TM) Cell-Signaling Regulation Technology for Development of New Cancer Therapies
- FuelCell Energy Board of Directors Names President and Chief Executive Officer R. Daniel Brdar to the Additional Post of Chairman
- FAU Licenses Novel Cancer Therapy to CHS Resources LLC
- TRACON Pharmaceuticals Assembles Industry-Leading Management Team to Support Development of Targeted Cancer Therapy Pipeline
- Xenomics Names Key Pharmaceutical Industry Executive John Brancaccio to Board of Directors and to Audit Committee
- Biotech Cancer Therapy Gets Approval in China
- Genes Linked to Prostate Cancer
- CorSolutions' Board of Directors Names Angus Duthie Chief Executive Officer
- Research And Markets: Will High Investment In The Cancer Therapy Market Lead To Improvements?
 |
 |
User Comments (0)
RSS Feeds